AIM
RPTX

ARK Investment Management’s Repare Therapeutics RPTX Stock Holding History

ARK Investment Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,124,483
Closed -$1.11M – 197
2025
Q1 		$1.11M Sell
1,124,483
-875,514
-44% -$1.06M 0.01% 168
2024
Q4 		$2.62M Sell
1,999,997
-509,740
-20% -$1.52M 0.02% 123
2024
Q3 		$8.63M Sell
2,509,737
-120,627
-5% -$397K 0.08% 101
2024
Q2 		$8.68M Sell
2,630,364
-73,419
-3% -$262K 0.08% 99
2024
Q1 		$12.7M Sell
2,703,783
-117,777
-4% -$755K 0.09% 99
2023
Q4 		$20.6M Buy
2,821,560
+200,677
+8% +$1.12M 0.12% 81
2023
Q3 		$31.7M Sell
2,620,883
-7,190
-0.3% -$74.2K 0.24% 51
2023
Q2 		$27.8M Sell
2,628,073
-109,251
-4% -$1.13M 0.18% 67
2023
Q1 		$26.9M Buy
2,737,324
+309,269
+13% +$3.55M 0.19% 56
2022
Q4 		$35.7M Sell
2,428,055
-203,973
-8% -$3.05M 0.31% 45
2022
Q3 		$31.9M Sell
2,632,028
-147,303
-5% -$1.9M 0.22% 60
2022
Q2 		$25.5M Sell
2,779,331
-95,984
-3% -$1.13M 0.15% 79
2022
Q1 		$40.9M Sell
2,875,315
-105,521
-4% -$1.56M 0.17% 75
2021
Q4 		$62.9M Buy
2,980,836
+14,097
+0.5% +$332K 0.19% 74
2021
Q3 		$77.8M Buy
2,966,739
+939,579
+46% +$30.4M 0.19% 81
2021
Q2 		$63.2M Buy
2,027,160
+668,571
+49% +$21.9M 0.12% 112
2021
Q1 		$41.7M Buy
1,358,589
+723,196
+114% +$24.6M 0.08% 143
2020
Q4 		$21.8M Buy
+635,393
New +$19M 0.06% 135

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ARK Investment Management's RPTX Position: Q2 2025 in Review

ARK Investment Management sold out of Repare Therapeutics (RPTX) in Q2 2025, closing a stake of 1,124,483 shares — an estimated $1.11M sold.

ARK Investment Management first reported a position in RPTX in Q4 2020 and held it in 18 quarters. The position peaked at $77.8M in Q3 2021. 50 funds tracked by Wall St. Rank hold RPTX as of Q2 2025.

  • ARK Investment Management reported no remaining Repare Therapeutics position as of Q2 2025 after selling out during the quarter.
  • ARK Investment Management sold 1,124,483 Repare Therapeutics shares in Q2 2025, an estimated $1.11M.
  • ARK Investment Management first reported a position in Repare Therapeutics in Q4 2020 and held it in 18 quarters.
  • ARK Investment Management's Repare Therapeutics position peaked at $77.8M in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2025.

Based on ARK Investment Management's 13F filing for Q2 2025, filed 30 Jul 2025.